Product ID |
Product Name |
CAS# |
Purity |
Y3138679 |
tert-butylN-[(1R)-1-(3-aminophenyl)ethyl]carbamate |
2241107-77-5 |
95% |
Y3270805 |
1-(6-methoxypyridin-3-yl)ethan-1-amine dihydrochloride |
2250241-89-3 |
95% |
Y3260878 |
(R)-1-(4-(tert-Butyl)phenyl)ethanamine hydrochloride |
2829279-67-4 |
95% |
Y3258291 |
(S)-2-(4-(tert-Butyl)phenyl)-2-(methylamino)ethanol hydrochloride |
2829279-68-5 |
95% |
Y3268215 |
(S)-1-(6-Bromopyridin-2-yl)ethanamine dihydrochloride |
2829279-69-6 |
95% |
Y3251001 |
(R)-1-(6-Bromopyridin-2-yl)ethanamine dihydrochloride |
2829279-70-9 |
95% |
Y3144146 |
2,6-Dibromo-4-hydroxybenzoic Acid |
1935194-66-3 |
95% |
Y3288850 |
1-Ethyl-3-morpholino-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile |
374548-18-2 |
98% |
Y3144107 |
6-(methoxycarbonyl)-1H-indole-3-carboxylicacid |
773869-62-8 |
95% |
Y3144092 |
tert-butyl (2R)-2-{[(tert-butoxy)carbonyl]amino}-5-hydroxypentanoate |
240135-68-6 |
95% |
Y3313019 |
Echitaminic acid |
7163-44-2 |
95% |
Y3312460 |
Kopsininic acid |
7222-19-7 |
98% |
Y3318133 |
Condurango glycoside E2 |
157000-65-2 |
95% |
Y3314538 |
Condurango glycoside E |
115784-07-1 |
95% |
Y3318319 |
Stigmast-5-en-7-one, 3-(acetyloxy)-, (3β)- |
18376-53-9 |
98% |
Y3305815 |
Isoscutellarein 8-O-glucuronide |
56317-09-0 |
95% |
Y3309436 |
Salicyltremuloidin |
10059-19-5 |
98% |
Y3315664 |
Semicochliodinol A |
194224-72-1 |
95% |
Y3309177 |
Stigmast-5-ene-3,7-dione |
206554-44-1 |
NMR 98% |
Y3305390 |
3-acetyl-11-keto-ursolic acid |
35959-01-4 |
98% |
Y3144079 |
TRPM4-IN-2 |
667411-04-3 |
99.21% |
Y3122462 |
MS177 |
2225938-86-1 |
98% |
Y3309099 |
SN32976 |
1246202-11-8 |
95% |
Y3122492 |
CDK9 inhibitor HH1 |
204188-41-0 |
97.97% |
Y3308639 |
CORT-108297 Enantiomer |
1956435-30-5 |
99% |
Y3307183 |
SB-734117 |
607368-97-8 |
98% |
Y3293176 |
KIF18A-IN-2 |
2600559-20-2 |
99% |
Y3294715 |
KIF18A-IN-3 |
2600577-49-7 |
99% |
Y3146856 |
Povorcitinib phosphate |
1637677-33-8 |
98.36% |
Y3297601 |
NRX-1933 |
2763260-30-4 |
99% |
Y3143184 |
BRM/BRG1 ATP Inhibitor-2 |
2368900-77-8 |
98% |
Y3292277 |
TNIK-IN-3 |
2754265-25-1 |
99% |
Y3143219 |
USP8-IN-1 |
2477650-96-5 |
99.61% |
Y3143222 |
INCB13739 |
869974-19-6 |
99% |
Y3107170 |
RLX-33 |
2784577-71-3 |
98% |
Y3293525 |
ABBV-318 |
1802848-94-7 |
98% |
Y3143197 |
Etavopivat |
2245053-57-8 |
98.70% |
Y3287691 |
DS-3801b |
1369412-66-7 |
99% |
Y3134033 |
Antiproliferative agent-14 |
1885900-35-5 |
98% |
Y3304985 |
(SP-4-2)-Bromo[1,1'-[(oxydi-2,1-phenylene)]bis[1,1-diphenylphosphine-P]](2,4,6-trimethylphenyl)nickel |
2097609-32-8 |
95% |
Y3102187 |
[[3,6-Dimethoxy-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl-C1']bis(1,1-dimethylethyl)phosphine-P](3-2-propen-1-yl)-Palladium(1+), 1,1,1-trifluoromethanesulfonate (1:1) |
1798782-15-6 |
95% |
Y3308392 |
goshuyamide I |
126223-62-9 |
98% |
Y3287732 |
S-Adenosyl-L-methionine-d3 |
68684-40-2 |
95% |
Y3306628 |
EGR240 |
1415683-79-2 |
99% |
Y3286870 |
EPZ-719 |
2697176-16-0 |
99% |
Y3134044 |
1-(cyclopropanesulfonyl)-4-fluorobenzene |
871657-78-2 |
95% |
Y3287070 |
4-(1-amino-2,2,2-trifluoroethyl)benzonitrilehydrochloride |
2375268-83-8 |
95% |
Y3134035 |
(3R)-3-amino-3-(4-chlorophenyl)propanoicacidhydrochloride |
930769-53-2 |
95% |
Y3106390 |
2-Chloro-N-(2-fluoro-4-nitrophenyl)-N-methylacetamide |
911998-05-5 |
95% |
Y3106394 |
3,5-Di(9H-carbazol-9-yl)aniline |
1384449-05-1 |
95% |
Y3291284 |
1,3-Propanediamine, 2-fluoro-N1,N1,N3,N3-tetrakis(phenylmethyl)- |
726190-66-5 |
95% |
Y3106395 |
Benzyl 3-(furan-2-yl)-3-oxopropanoate |
877236-29-8 |
95% |
Y3294497 |
6-[4-[6,8,8-trimethyl-2-oxo-9-(3-sulfopropyl)pyrano[3,2-g]quinolin-3-yl]pyridin-1-ium-1-yl]hexanoate |
811785-95-2 |
95% |
Y3310300 |
PI3K-IN-38 |
1382979-64-7 |
99% |
Y3293953 |
(1R,2S)-ethyl 2-(((methylthio)carbonothioyl)oxy)cyclopentanecarboxylate |
162084-62-0 |
95% |
Y3294733 |
Methyl 6-bromo-2-cyclopropyl-1H-benzo[d]imidazole-4-carboxylate |
1637774-71-0 |
95% |
Y3131824 |
4-(difluoromethoxy)-2-fluorobenzene-1-sulfonyl chloride |
1261825-39-1 |
95% |
Y3102884 |
2-[(6-chloropyridin-3-yl)oxy]acetic acid |
234109-28-5 |
98% |
Y3131827 |
(2S)-1-cyclopropylpropan-2-amine hydrochloride |
2171163-74-7 |
95% |
Y3131810 |
methyl 2-ethenyl-1,3-thiazole-5-carboxylate |
1783261-91-5 |
95% |
Y3131823 |
2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-(4-iodophenyl)acetic acid |
1869103-50-3 |
95% |
Y3134040 |
1-chloro-6-fluoroisoquinoline-3-carboxylic acid |
1599376-28-9 |
95% |
Y3134048 |
5-{[2-(thiophen-2-yl)ethyl]amino}-2,3-dihydro-1,3,4-thiadiazole-2-thione |
879361-78-1 |
99% |
Y3110202 |
4,4''-Divinyl-5'-(4-vinylphenyl)-1,1':3',1''-terphenyl |
944155-02-6 |
98% |
Y3134068 |
rac-methyl(2R,4R)-4-aminothiolane-2-carboxylatehydrochloride,cis |
2287246-95-9 |
95% |
Y3313633 |
L-20-Methylene-pregn-4-ene-3,2,1-dione |
2257421-80-8 |
95% |
Y3134060 |
methyl5-iminopyrrolidine-3-carboxylatehydrochloride |
2361635-93-8 |
95% |
Y1334529 |
1,4,15,18-Tetraoxacyclooctacosane-5,14,19,28-tetrone |
74783-03-2 |
95%+ |
Y3110341 |
6-Bromo-3-methyl-2-nitrophenol |
1195533-07-3 |
95%+ |
Y1335653 |
(R)-5-Amino-4-methylpentan-1-ol hydrochloride |
2734714-91-9 |
98% |
Y1337475 |
[4-[3,5-Bis(4-phosphonophenyl)phenyl]phenyl]phosphonic acid |
1045720-71-5 |
98% |
Y3271202 |
((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
886538-48-3 |
97% |
Y3316965 |
2-Amino-2-(4-(methylthio)phenyl)acetic acid hydrochloride |
2757729-92-1 |
95% |
Y1333416 |
(5-Methoxy-[1,1'-biphenyl]-3-yl)boronic acid |
1111181-69-1 |
95% |
Y3264963 |
(E)-(3-Bromoprop-1-en-1-yl)benzene |
26146-77-0 |
97% mix TBC as stabilizer |
Y3258016 |
(R)-2-Amino-2-(naphthalen-1-yl)ethanol hydrochloride |
2829279-71-0 |
95% |
Y3264967 |
Dibenzyl 2-aminopentanedioate hydrochloride |
2828432-29-5 |
97% |
Y3254849 |
Iridium-(4,4'-difluoro-2,2'-bipyridine-N1,N1')bis[5-methyl-2-(4-methyl-2-pyridinyl-N)phenyl-C]-hexafluorophosphate |
2828438-04-4 |
97% |
Y3263089 |
Ethyl (S)-1-((1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)carbamoyl)cyclobutane-1-carboxylate |
2285373-84-2 |
95% |
Y3260863 |
Iridium-(4,4'-difluoro-2,2'-bipyridine-N1,N1')bis[3,5-difluoro-2-(5-trifluoromethyl-2-pyridinyl-N)phenyl-C]-hexafluorophosphate |
2828437-86-9 |
97% |
Y3260372 |
(4S,4'S)-4,4'-Diisopropyl-1,1'-bis(4-(trifluoromethyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole |
2374958-84-4 |
97% |
Y1338461 |
(S)-2-(2-(Bis(3,5-bis(trifluoromethyl)phenyl)phosphanyl)phenyl)-4-(tert-butyl)-4,5-dihydrooxazole |
1092491-37-6 |
98% |
Y3266066 |
(R)-(4,4',6,6'-Tetramethoxy-[1,1'-biphenyl]-2,2'-diyl)bis(bis(3,5-bis(trimethylsilyl)phenyl)phosphane) |
2829281-61-8 |
98% |
Y3271979 |
Iridium-(1,10-phenanthroline-N1,N10)bis[(3-fluoro-5-trifluoromethyl)-2-(5-trifluoromethyl-2-pyridinyl-N)phenyl-C]-hexafluorophosphate |
2828437-79-0 |
95% |
Y3265969 |
Iridium-(1,10-phenanthroline-N1,N10)bis[5-methyl-2-(4-methyl-2-pyridinyl-N)phenyl-C]-(OC-6-33)-hexafluorophosphate |
2828447-21-6 |
95% |
Y3263633 |
2-Chloro-4-fluoro-5-nitropyridine |
1261803-05-7 |
95% |
Y3262870 |
(SP-4-1)-Nickelate(4-), [[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl-N21,N22,N23,N24)tetrakis[benzoato]](6-)]-, tetrahydrogen |
41699-92-7 |
97% |
Y3266927 |
2,5-Dioxopyrrolidin-1-yl 3-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)propanoate |
2639395-34-7 |
98% |
Y3264190 |
LS-102 |
1456891-34-1 |
98% |
Y3272066 |
(5aS,10bR)-2-(3,5-Bis(trifluoromethyl)phenyl)-4,5a,6,10b-tetrahydroindeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate |
1214711-40-6 |
98% |
Y1338604 |
(4S,4'S)-1,1'-Di([1,1'-biphenyl]-4-yl)-4,4'-diisopropyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole |
2374958-86-6 |
97% |
Y3308984 |
(2R)-2-(trifluoroacetamido)propanoic acid |
7592-26-9 |
97% |
Y1337751 |
2,9-Diaminoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone |
49546-23-8 |
95% |
Y3265334 |
Iridium-(4,4'-dimethoxy-2,2'-bipyridine-N1,N1')bis[3,5-difluoro-2-(5-methyl-2-pyridinyl-N)phenyl-C]-hexafluorophosphate |
2828437-98-3 |
97% |
Y3262082 |
2-(4-Methyl-1H-imidazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine hydrochloride |
2828440-27-1 |
95+% |
Y1344557 |
3-Bromo-4-fluorophthalic acid |
2828433-78-7 |
98% |
Y3263328 |
Iridium-(1,10-phenanthroline-N1,N10)bis[3,5-difluoro-2-(5-fluoro-2-pyridinyl-N)phenyl-C]-hexafluorophosphate |
2828437-84-7 |
95% |
Y3270467 |
tert-Butyl (1-imino-1-oxidohexahydro-1l6-thiopyran-4-yl)(methyl)carbamate |
2816674-57-2 |
97% |
Y1341688 |
2,6-Dimethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde |
2369068-26-6 |
98% |
Y3263262 |
Iridium-bis[3,5-difluoro-2-(2-pyridinyl-N)phenyl-C](4,4'-dimethoxy-2,2'-bipyridine-N1,N1')-(OC-6-33)-hexafluorophosphate |
1887093-05-1 |
97% |